EICHORCondition: Lung Carcinoma · Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This is an open-label, multicenter, phase II study. The purpose of this study is to evaluate the safety, tolerability and preliminary anti-tumor activity of SKB518 in patients with lung cancer. Eligible subjects will receive SKB518 monotherapy, until radiographic disease progression, intolerable toxicity, discontinuation of study treatment required by the subject, or other protocol-specified treatment discontinuation criteria, whichever occurs first.
This description comes directly from the study's public registry record.
Xin Li · 086-010-58202512 · lixin@kelun.com
Always discuss trial participation with your own doctor first.
| Cancer Hospital, Chinese Academy of Medical Sciences, Shenzhen Center | Shenzhen, Guangdong, China | Recruiting |
| Cancer Hospital of Guangxi Medical University | Nanning, Guangxi, China | Recruiting |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou, Henan, China | Recruiting |
| Hubei Cancer Hospital | Wuhan, Hubei, China | Recruiting |
| Renmin Hospital of Wuhan University | Wuhan, Hubei, China | Recruiting |
| Xiangyang Central Hospital | Xiangyang, Hubei, China | Recruiting |
| Hunan Cancer Hospital | Changsha, Hunan, China | Recruiting |
| Jiangxi Cancer Hospital | Nanchang, Jiangxi, China | Recruiting |
| Cancer Hospital of Shandong First Medical University | Jinan, Shandong, China | Recruiting |
| Shanxi Cancer Hospital | Taiyuan, Shanxi, China | Recruiting |
| Affiliated Cancer Hospital of Xinjiang Medical University | Ürümqi, Xinjiang, China | Recruiting |
| Yunnan Cancer Hospital | Kunming, Yunnan, China | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07019675